Urine-based glucose monitoring is a method used to measure glucose levels in urine samples. While not as accurate as blood-based monitoring, urine testing can provide an indication of glucose levels and help in diabetes management.
The global Urine Based Glucose Monitoring market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The market for urine-based glucose monitoring is driven by factors such as its simplicity and cost-effectiveness, making it a viable option in certain healthcare settings or resource-limited environments. However, the growing popularity of blood-based and non-invasive glucose monitoring methods may impact the market's growth in the long term.
Report Covers:
This report presents an overview of global market for Urine Based Glucose Monitoring, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Urine Based Glucose Monitoring, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Urine Based Glucose Monitoring, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Urine Based Glucose Monitoring sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Urine Based Glucose Monitoring market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Urine Based Glucose Monitoring sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Segment by Type
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Urine Based Glucose Monitoring in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Urine Based Glucose Monitoring manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urine Based Glucose Monitoring sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Urine Based Glucose Monitoring Product Introduction
1.2 Market by Type
1.2.1 Global Urine Based Glucose Monitoring Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Wearable Blood Glucose Monitoring Systems
1.2.3 Table Top Blood Glucose Monitoring Systems
1.3 Market by Application
1.3.1 Global Urine Based Glucose Monitoring Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Urine Based Glucose Monitoring Sales Estimates and Forecasts 2019-2030
2.2 Global Urine Based Glucose Monitoring Revenue by Region
2.2.1 Global Urine Based Glucose Monitoring Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Urine Based Glucose Monitoring Revenue by Region (2019-2024)
2.2.3 Global Urine Based Glucose Monitoring Revenue by Region (2025-2030)
2.2.4 Global Urine Based Glucose Monitoring Revenue Market Share by Region (2019-2030)
2.3 Global Urine Based Glucose Monitoring Sales Estimates and Forecasts 2019-2030
2.4 Global Urine Based Glucose Monitoring Sales by Region
2.4.1 Global Urine Based Glucose Monitoring Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Urine Based Glucose Monitoring Sales by Region (2019-2024)
2.4.3 Global Urine Based Glucose Monitoring Sales by Region (2025-2030)
2.4.4 Global Urine Based Glucose Monitoring Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Urine Based Glucose Monitoring Sales by Manufacturers
3.1.1 Global Urine Based Glucose Monitoring Sales by Manufacturers (2019-2024)
3.1.2 Global Urine Based Glucose Monitoring Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Urine Based Glucose Monitoring in 2023
3.2 Global Urine Based Glucose Monitoring Revenue by Manufacturers
3.2.1 Global Urine Based Glucose Monitoring Revenue by Manufacturers (2019-2024)
3.2.2 Global Urine Based Glucose Monitoring Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Urine Based Glucose Monitoring Revenue in 2023
3.3 Global Key Players of Urine Based Glucose Monitoring, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Urine Based Glucose Monitoring Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Urine Based Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Urine Based Glucose Monitoring, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Urine Based Glucose Monitoring, Product Offered and Application
3.8 Global Key Manufacturers of Urine Based Glucose Monitoring, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Urine Based Glucose Monitoring Sales by Type
4.1.1 Global Urine Based Glucose Monitoring Historical Sales by Type (2019-2024)
4.1.2 Global Urine Based Glucose Monitoring Forecasted Sales by Type (2025-2030)
4.1.3 Global Urine Based Glucose Monitoring Sales Market Share by Type (2019-2030)
4.2 Global Urine Based Glucose Monitoring Revenue by Type
4.2.1 Global Urine Based Glucose Monitoring Historical Revenue by Type (2019-2024)
4.2.2 Global Urine Based Glucose Monitoring Forecasted Revenue by Type (2025-2030)
4.2.3 Global Urine Based Glucose Monitoring Revenue Market Share by Type (2019-2030)
4.3 Global Urine Based Glucose Monitoring Price by Type
4.3.1 Global Urine Based Glucose Monitoring Price by Type (2019-2024)
4.3.2 Global Urine Based Glucose Monitoring Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Urine Based Glucose Monitoring Sales by Application
5.1.1 Global Urine Based Glucose Monitoring Historical Sales by Application (2019-2024)
5.1.2 Global Urine Based Glucose Monitoring Forecasted Sales by Application (2025-2030)
5.1.3 Global Urine Based Glucose Monitoring Sales Market Share by Application (2019-2030)
5.2 Global Urine Based Glucose Monitoring Revenue by Application
5.2.1 Global Urine Based Glucose Monitoring Historical Revenue by Application (2019-2024)
5.2.2 Global Urine Based Glucose Monitoring Forecasted Revenue by Application (2025-2030)
5.2.3 Global Urine Based Glucose Monitoring Revenue Market Share by Application (2019-2030)
5.3 Global Urine Based Glucose Monitoring Price by Application
5.3.1 Global Urine Based Glucose Monitoring Price by Application (2019-2024)
5.3.2 Global Urine Based Glucose Monitoring Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Urine Based Glucose Monitoring Market Size by Type
6.1.1 US & Canada Urine Based Glucose Monitoring Sales by Type (2019-2030)
6.1.2 US & Canada Urine Based Glucose Monitoring Revenue by Type (2019-2030)
6.2 US & Canada Urine Based Glucose Monitoring Market Size by Application
6.2.1 US & Canada Urine Based Glucose Monitoring Sales by Application (2019-2030)
6.2.2 US & Canada Urine Based Glucose Monitoring Revenue by Application (2019-2030)
6.3 US & Canada Urine Based Glucose Monitoring Market Size by Country
6.3.1 US & Canada Urine Based Glucose Monitoring Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Urine Based Glucose Monitoring Sales by Country (2019-2030)
6.3.3 US & Canada Urine Based Glucose Monitoring Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Urine Based Glucose Monitoring Market Size by Type
7.1.1 Europe Urine Based Glucose Monitoring Sales by Type (2019-2030)
7.1.2 Europe Urine Based Glucose Monitoring Revenue by Type (2019-2030)
7.2 Europe Urine Based Glucose Monitoring Market Size by Application
7.2.1 Europe Urine Based Glucose Monitoring Sales by Application (2019-2030)
7.2.2 Europe Urine Based Glucose Monitoring Revenue by Application (2019-2030)
7.3 Europe Urine Based Glucose Monitoring Market Size by Country
7.3.1 Europe Urine Based Glucose Monitoring Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Urine Based Glucose Monitoring Sales by Country (2019-2030)
7.3.3 Europe Urine Based Glucose Monitoring Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Urine Based Glucose Monitoring Market Size
8.1.1 China Urine Based Glucose Monitoring Sales (2019-2030)
8.1.2 China Urine Based Glucose Monitoring Revenue (2019-2030)
8.2 China Urine Based Glucose Monitoring Market Size by Application
8.2.1 China Urine Based Glucose Monitoring Sales by Application (2019-2030)
8.2.2 China Urine Based Glucose Monitoring Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Urine Based Glucose Monitoring Market Size by Type
9.1.1 Asia Urine Based Glucose Monitoring Sales by Type (2019-2030)
9.1.2 Asia Urine Based Glucose Monitoring Revenue by Type (2019-2030)
9.2 Asia Urine Based Glucose Monitoring Market Size by Application
9.2.1 Asia Urine Based Glucose Monitoring Sales by Application (2019-2030)
9.2.2 Asia Urine Based Glucose Monitoring Revenue by Application (2019-2030)
9.3 Asia Urine Based Glucose Monitoring Sales by Region
9.3.1 Asia Urine Based Glucose Monitoring Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Urine Based Glucose Monitoring Revenue by Region (2019-2030)
9.3.3 Asia Urine Based Glucose Monitoring Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Urine Based Glucose Monitoring Market Size by Type
10.1.1 Middle East, Africa and Latin America Urine Based Glucose Monitoring Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Urine Based Glucose Monitoring Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Urine Based Glucose Monitoring Market Size by Application
10.2.1 Middle East, Africa and Latin America Urine Based Glucose Monitoring Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Urine Based Glucose Monitoring Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Urine Based Glucose Monitoring Sales by Country
10.3.1 Middle East, Africa and Latin America Urine Based Glucose Monitoring Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Urine Based Glucose Monitoring Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Urine Based Glucose Monitoring Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Overview
11.1.3 Abbott Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Abbott Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Medtronic
11.2.1 Medtronic Company Information
11.2.2 Medtronic Overview
11.2.3 Medtronic Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Medtronic Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medtronic Recent Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Overview
11.3.3 Roche Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Roche Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Information
11.4.2 Bayer AG Overview
11.4.3 Bayer AG Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Bayer AG Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer AG Recent Developments
11.5 B. Braun
11.5.1 B. Braun Company Information
11.5.2 B. Braun Overview
11.5.3 B. Braun Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 B. Braun Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Recent Developments
11.6 Nipro Diagnostics
11.6.1 Nipro Diagnostics Company Information
11.6.2 Nipro Diagnostics Overview
11.6.3 Nipro Diagnostics Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Nipro Diagnostics Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nipro Diagnostics Recent Developments
11.7 Life Scan Inc.(J&J)
11.7.1 Life Scan Inc.(J&J) Company Information
11.7.2 Life Scan Inc.(J&J) Overview
11.7.3 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Life Scan Inc.(J&J) Recent Developments
11.8 Arkray Devices
11.8.1 Arkray Devices Company Information
11.8.2 Arkray Devices Overview
11.8.3 Arkray Devices Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Arkray Devices Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Arkray Devices Recent Developments
11.9 Nova Biomedical
11.9.1 Nova Biomedical Company Information
11.9.2 Nova Biomedical Overview
11.9.3 Nova Biomedical Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Nova Biomedical Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nova Biomedical Recent Developments
11.10 Bionime Corporation
11.10.1 Bionime Corporation Company Information
11.10.2 Bionime Corporation Overview
11.10.3 Bionime Corporation Urine Based Glucose Monitoring Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Bionime Corporation Urine Based Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bionime Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Urine Based Glucose Monitoring Industry Chain Analysis
12.2 Urine Based Glucose Monitoring Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Urine Based Glucose Monitoring Production Mode & Process
12.4 Urine Based Glucose Monitoring Sales and Marketing
12.4.1 Urine Based Glucose Monitoring Sales Channels
12.4.2 Urine Based Glucose Monitoring Distributors
12.5 Urine Based Glucose Monitoring Customers
13 Market Dynamics
13.1 Urine Based Glucose Monitoring Industry Trends
13.2 Urine Based Glucose Monitoring Market Drivers
13.3 Urine Based Glucose Monitoring Market Challenges
13.4 Urine Based Glucose Monitoring Market Restraints
14 Key Findings in The Global Urine Based Glucose Monitoring Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
听
听
*If Applicable.
